1. Home
  2. AIRE vs VNRX Comparison

AIRE vs VNRX Comparison

Compare AIRE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

N/A

Current Price

$0.44

Market Cap

40.7M

Sector

N/A

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

N/A

Current Price

$0.27

Market Cap

38.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRE
VNRX
Founded
2021
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.7M
38.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AIRE
VNRX
Price
$0.44
$0.27
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$2.00
$3.17
AVG Volume (30 Days)
3.6M
2.8M
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,149,567.00
$1,472,007.00
Revenue This Year
$411.48
$55.33
Revenue Next Year
$141.39
$493.79
P/E Ratio
N/A
N/A
Revenue Growth
994.18
14.48
52 Week Low
$0.14
$0.23
52 Week High
$4.49
$0.94

Technical Indicators

Market Signals
Indicator
AIRE
VNRX
Relative Strength Index (RSI) 39.80 36.72
Support Level $0.51 $0.23
Resistance Level $0.53 $0.31
Average True Range (ATR) 0.04 0.03
MACD -0.00 0.00
Stochastic Oscillator 2.60 32.56

Price Performance

Historical Comparison
AIRE
VNRX

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: